• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

PhotoCure ASA

+ Add to Watchlist


2.210 EUR 0.009 0.41%

As of 04:09:38 ET on 10/24/2014.

Snapshot for PhotoCure ASA (PHS)

Open: 2.218 Day's Range: 2.173 - 2.218 Volume: 0
Previous Close: 2.219 52wk Range: 2.112 - 4.444 1-Yr Rtn: -49.89%

Stock Chart for PHS

No chart data available.
  • PHS:GR 2.210
  • 1D
  • 1M
  • 1Y
Interactive PHS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 3.5462
Relative P/E vs. DAX -
Earnings Per Share (NOK) (ttm) -
Est. EPS (NOK) (12/2014) 5.1800
Est. PEG Ratio -
Market Cap (M EUR) 47.28
Shares Outstanding (M) 21.39
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (NOK) 2.0000
Dividend Ex-Date 05/23/2013
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHS

  • Revenue
  • Net Income (M/NOK)
  • Profit Margin (%)

Company Profile & Key Executives for PHS

PhotoCure ASA develops and produces pharmaceutical photodynamic therapy products and devices. The Company utilizes light-activated drugs in the treatment of cancer and other medical conditions. PhotoCure markets Metvix, a cream for the treatment of skin disorders, and the Curelight lamp to be used with the cream. The Company works with international research centers.

Kjetil HestdalPresident/CEOErik DahlChief Financial Officer
Kathleen DeardorffChief Operating OfficerInger Ferner HeglundVP:Research & Development
More Company Profile & Key Executives for PHS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil